Dual inhibition of AKT ‐m TOR and AR signaling by targeting HDAC 3 in PTEN ‐ or SPOP ‐mutated prostate cancer

Document Details

Document Type
Pub Defense Publication
Publication Date
Mar 09, 2018
Source ID
10.15252/emmm.201708478

Entities

People

  • Dejie Wang
  • Di Wu
  • Haojie Huang
  • Jennifer J. Westendorf
  • Jian An
  • Jun Zhang
  • Junhui Chen
  • Liguo Wang
  • Linlin Ma
  • R. Jeffrey Karnes
  • Runzhi Zhu
  • Saravut John Weroha
  • Shangqian Wang
  • Tao Ma
  • Wanhai Xu
  • William Cao
  • Xiaonan Hou
  • Xin Jin
  • Yang Bai
  • Yinhui Yang
  • Yu Chen
  • Yundong He
  • Yunqian Pan
  • Yuqian Yan
  • Zhendong Yu

Organizations

  • Foundation for the National Institutes of Health
  • Harbin Medical University
  • Jiangsu University
  • Mayo Clinic
  • Mayo Clinic Cancer Center
  • Mayo Medical School
  • Memorial Sloan Kettering Cancer Center
  • Nanchang University
  • National Institutes of Health
  • National Natural Science Foundation of China
  • Peking University
  • United States Department of Defense